FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

385108009: Conventional release cutaneous solution (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479370017 Cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module
3558864015 Conventional release cutaneous solution (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3558865019 Conventional release cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous solution Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Is a Drug solution false Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has basic dose form Solution true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely lactic acid (as ammonium lactate) 167 milligram/1 milliliter and salicylic acid 167 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely minoxidil 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely amorolfine (as amorolfine hydrochloride) 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely minoxidil 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely minoxidil 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely iodine 50 milligram/1 milliliter and potassium iodide 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 75 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely permethrin 10 milligram/1 gram conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely aluminium chloride 350 milligram/1 milliliter and isopropyl alcohol 325 milligram/milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 0.1% topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 0.1% topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 0.1% topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium hydroxide 10% topical solution 20 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium hydroxide 10% topical solution (Special Order) 20 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Actikerall 5 mg/g / 100 mg/g cutaneous solution (Almirall Ltd) Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution 25 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Actikerall 5 mg/g / 100 mg/g cutaneous solution (Almirall Ltd) 25 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 1% cutaneous solution Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 1% cutaneous solution (Special Order) Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution (Special Order) Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 1% cutaneous solution 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 1% cutaneous solution (Special Order) 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution (Special Order) 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution 10 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Phenol 2% cutaneous solution (Special Order) 10 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Propylene glycol 50% topical solution Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Propylene glycol 50% topical solution (Special Order) Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Propylene glycol 50% topical solution 100 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Propylene glycol 50% topical solution 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Propylene glycol 50% topical solution (Special Order) 1 ml Has dispensed dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier

Start Page 2 of 4 Next End

This concept is not in any reference sets

Back to Start